Literature DB >> 10086321

Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin.

M Murata1, A Takahashi, I Saito, S Kawanishi.   

Abstract

Streptozotocin (STZ) is known to induce insulin-dependent diabetes mellitus via DNA damage in experimental animals. The mechanism of induction of DNA damage by STZ was investigated in vitro, using a human cell line and 32P-labeled DNA fragments isolated from human genes. STZ induced cellular DNA damage and apoptosis, and frequently initiated DNA modification at guanines, especially at the middle guanine in runs of three and at the guanine at the 3'-end of runs of two guanines, similar to N-methyl-N-nitrosourea, a typical methylating agent. Scavengers for reactive oxygen species or nitric oxide did not inhibit the induction of DNA damage by STZ. On the other hand, damage induction was inhibited by sodium acetate and sodium chloride, which can reduce the reactivity of methylating agents to DNA via the sodium cation. These results suggest that STZ induces DNA damage by methylation of guanines via methyl cations. This alkylation may be responsible for triggering apoptosis, and subsequently diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086321     DOI: 10.1016/s0006-2952(98)00370-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  30 in total

Review 1.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

2.  Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes.

Authors:  Kousuke Noda; Shintaro Nakao; Souska Zandi; Verena Engelstädter; Yukihiko Mashima; Ali Hafezi-Moghadam
Journal:  Exp Eye Res       Date:  2009-07-25       Impact factor: 3.467

3.  RhoB loss prevents streptozotocin-induced diabetes and ameliorates diabetic complications in mice.

Authors:  Arturo Bravo-Nuevo; Hikaru Sugimoto; Seema Iyer; Zachary Fallon; Jason M Lucas; Shiva Kazerounian; George C Prendergast; Raghu Kalluri; Nathan I Shapiro; Laura E Benjamin
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 4.  Animal models of gestational diabetes: characteristics and consequences to the brain and behavior of the offspring.

Authors:  Ricardo Augusto Leoni De Sousa
Journal:  Metab Brain Dis       Date:  2021-01-05       Impact factor: 3.584

5.  Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.

Authors:  Ming Tong; Alexander Neusner; Lisa Longato; Margot Lawton; Jack R Wands; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

6.  Role of melatonin on diabetes-related metabolic disorders.

Authors:  Javier Espino; José A Pariente; Ana B Rodríguez
Journal:  World J Diabetes       Date:  2011-06-15

7.  Streptozotocin-resistant BRIN-BD11 cells possess wide spectrum of toxin tolerance and enhanced insulin-secretory capacity.

Authors:  Hui-Kang Liu; Jane T McCluskey; Neville H McClenghan; Peter R Flatt
Journal:  Endocrine       Date:  2007-09-29       Impact factor: 3.633

8.  Germ cell abnormalities in streptozotocin induced diabetic mice do not correlate with blood glucose level.

Authors:  Rohini Bose; Satish K Adiga; Fiona D'Souza; Sujith R Salian; Shubhashree Uppangala; Guruprasad Kalthur; Navya Jain; Raghu A Radhakrishnan; Nalini Bhat; Hanumantappa Krishnamurthy; Pratap Kumar
Journal:  J Assist Reprod Genet       Date:  2012-10-16       Impact factor: 3.412

9.  Cytotoxicity of streptozotocin on neuroendocrine cells of the pancreas and the gut.

Authors:  O Brenna; G Qvigstad; E Brenna; H L Waldum
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

10.  Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.

Authors:  Suzanne M de la Monte; Ming Tong; Margot Lawton; Lisa Longato
Journal:  Mol Neurodegener       Date:  2009-12-24       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.